BeiGene

BeiGene, Ltd. has proposed to change its name to BeOne Medicines Ltd. The new name is subject to shareholder approval and, once approved, use of the name will be phased in over 2025. There may be instances where “BeiGene” or “BeOne” are used to describe the company during this transition period. BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer. General Description: Senior Manager, Data Analysis and Operations will support BeiGene’s Commercial and Medical Affairs functions in Europe and New Markets regions with secondary data acquisition, data vendor management, channel data partnerships and data sharing, and adhoc data analysis. This role reports to the Senior Director, Data Strategy and BI (GBI), and will work...